InVivo Therapeutics (NVIV.OB +19.9%) rises sharply on heavy volume after announcing the FDA has...

|About: InVivo Therapeutics Holding... (NVIV)|By:, SA News Editor

InVivo Therapeutics (NVIV.OB +19.9%) rises sharply on heavy volume after announcing the FDA has approved its request for a Humanitarian Use Device designation for its biopolymer scaffolding product. The designation should help the company speed the product to market. A clinical trial submission is being reviewed by the FDA currently.